Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001157523-23-001404
Filing Date
2023-09-08
Accepted
2023-09-08 08:30:28
Documents
2
Period of Report
2023-09-08

Document Format Files

Seq Description Document Type Size
1 IMMUNOPRECISE ANTIBODIES LTD. 6-K a53550988.htm 6-K 8497
2 EXHIBIT 99.1 a53550988ex99_1.htm EX-99.1 4334
  Complete submission text file 0001157523-23-001404.txt   13818
Mailing Address 880 - 580 HORNBY STREET VANCOUVER A1 V6C3B6
Business Address 880 - 580 HORNBY STREET VANCOUVER A1 V6C3B6 6048060626
ImmunoPrecise Antibodies Ltd. (Filer) CIK: 0001715925 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0430
Type: 6-K | Act: 34 | File No.: 001-39530 | Film No.: 231243726
SIC: 2834 Pharmaceutical Preparations